PLASMA-LEVEL OF TUMOR-NECROSIS-FACTOR IN DISSEMINATED INTRAVASCULAR COAGULATION

被引:56
|
作者
WADA, H
OHIWA, M
KANEKO, T
TAMAKI, S
TANIGAWA, M
TAKAGI, M
MORI, Y
SHIRAKAWA, S
机构
[1] Second Department of Internal Medicine, Mie University School of Medicine, Tsu City, Mie Ken
关键词
TNF; ORGAN FAILURE; DIC;
D O I
10.1002/ajh.2830370302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The plasma level of tumor necrosis factor (TNF) was determined in 20 normal individuals, 52 patients with disseminated intravascular coagulation (DIC), 22 pre-DIC patients, and 39 non-DIC patients. TNF was not detected in the normal subjects, and the level was very low in non-DIC patients. However, the TNF level was significantly elevated in DIC patients, and it was moderately increased in pro-DIC patients shortly before the onset of DIC. This increase in circulating TNF may be associated with DIC. TNF was higher in DIC associated with solid cancer than in DIC associated with leukemia or sepsis. The increase in plasma TNF level was widely correlated with DIC score, and it was significantly increased in patients with poor prognosis. However, the plasma TNF level in DIC patients with organ failure was not significantly different from those without organ failure. We conclude that the increase in circulating TNF reflects the pathogenic factors in DIC rather than being a consequence of organ failure due to DIC.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 50 条
  • [11] Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation
    Okugawa, Y
    Wada, H
    Noda, T
    Sakakura, M
    Nakasaki, T
    Watanabe, R
    Deguchi, H
    Gabazza, EC
    Mori, Y
    Nishikawa, M
    Deguchi, K
    Nobori, T
    Shiku, H
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 65 (03) : 210 - 214
  • [12] Factor VIIa-AT Complex Is an Independent Prognostic Marker of Disseminated Intravascular Coagulation
    Lee, Joon Hee
    Gu, JaYoon
    Kim, Hyun Kyung
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (04) : 546 - 551
  • [13] DIFFERENTIAL TUMOR-NECROSIS-FACTOR PRODUCTION BY HUMAN MONOCYTE SUBSETS
    SZABO, G
    MILLERGRAZIANO, CL
    WU, JY
    TAKAYAMA, T
    KODYS, K
    JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 47 (03) : 206 - 216
  • [14] CIRCUMVENTION OF ATYPICAL MULTIDRUG-RESISTANCE WITH TUMOR-NECROSIS-FACTOR
    CIMOLI, G
    VALENTI, M
    PARODI, S
    DESESSA, F
    RUSSO, P
    JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (02): : 135 - 138
  • [15] RECOMBINANT TUMOR-NECROSIS-FACTOR FOR SUPERFICIAL BLADDER-TUMORS
    STERNBERG, CN
    ARENA, MG
    PANSADORO, V
    CALABRESI, F
    DAGNANO, I
    DECARLI, P
    ZEULI, M
    CANCRINI, A
    ROSENKAIMER, F
    ZUPI, G
    ANNALS OF ONCOLOGY, 1992, 3 (09) : 741 - 745
  • [16] TUMOR-NECROSIS-FACTOR (CACHECTIN) IN THE BIOLOGY OF SEPTIC SHOCK SYNDROME
    TRACEY, KJ
    CIRCULATORY SHOCK, 1991, 35 (02) : 123 - 128
  • [17] EFFECT OF RH TUMOR-NECROSIS-FACTOR ON EXPERIMENTAL INTRAOCULAR TUMORS
    WONG, VG
    VIOLA, RS
    CORNEA, 1991, 10 (02) : 131 - 135
  • [18] DETERMINATION OF TUMOR-NECROSIS-FACTOR IN BLISTER FLUIDS OF BULLOUS PEMPHIGOID
    TAKEMATSU, H
    OHTA, H
    TAGAMI, H
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1991, 283 (02) : 131 - 132
  • [19] THE ELEVATION OF PLASMA SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR LEVELS BY TNF INDUCTION THERAPY FOR PATIENTS WITH MALIGNANCY
    ABE, Y
    KIMURA, K
    HORIUCHI, A
    WATANABE, Y
    KIMURA, S
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (06): : 506 - 511
  • [20] Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation
    Ohkura, N
    Seo, G
    Kohno, I
    Kumeda, K
    Wada, H
    Kamikubo, Y
    Shiku, H
    Kato, H
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (06) : 309 - 319